# Imaging Inflammation in Alzheimer's Disease With 11C-ER176

> **NCT03744312** · PHASE1,PHASE2 · COMPLETED · sponsor: **Columbia University** · enrollment: 9 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** 11C-ER176
- **DRUG:** Florbetaben

## Key facts

- **NCT ID:** NCT03744312
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-10
- **Primary completion:** 2022-07-20
- **Final completion:** 2022-07-20
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03744312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03744312, "Imaging Inflammation in Alzheimer's Disease With 11C-ER176". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03744312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*